Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 13 Similar Profiles
Neoplasms
Medicine & Life Sciences
Dendritic Cells
Medicine & Life Sciences
Interleukin-2
Medicine & Life Sciences
T-Lymphocytes
Medicine & Life Sciences
Immunity
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Tumors
Chemical Compounds
Immunotherapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2003 2015
- 2 Finished
(CRCL) vaccine for Chronic Myelogenous Leukemia
3/1/04 → 4/30/15
Project: Research project › Research Project
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Immunotherapy
Leukemia
Vaccines
Chaperone rich cell lysates (CRCL)Natural adjuvants and*
7/1/03 → 6/30/06
Project: Research project › Exploratory/Developmental Grants
Dendritic Cells
Ovarian Neoplasms
Heat-Shock Proteins
Ascites
Cytotoxic T-Lymphocytes
Research Output 1986 2018
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies
Katsanis, E., Sapp, L. N., Varner, N., Koza, S., Stea, B. & Zeng, Y. Jan 1 2018 (Accepted/In press) In : Biology of Blood and Marrow Transplantation.Research output: Contribution to journal › Article
Hematologic Neoplasms
Bone Marrow Transplantation
Cyclophosphamide
Young Adult
Pediatrics
Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection
Graetz, R., Meyer, R., Shehab, K. & Katsanis, E. Jan 1 2018 (Accepted/In press) In : Transplant Infectious Disease.Research output: Contribution to journal › Article
Ureaplasma Infections
Ureaplasma
Hyperammonemia
Cell Transplantation
Brain Diseases
4
Citations
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: A CIBMTR analysis
Kanate, A. S. , Digilio, A. , Ahn, K. W. , Al Malki, M. , Jacobsen, E. , Steinberg, A. , Hamerschlak, N. , Kharfan-Dabaja, M. , Salit, R. , Ball, E. , Bashir, Q. , Cashen, A. , Couriel, D. , Diez-Martin, J. , Katsanis, E. , Linhares, Y. , Mori, S. , Nash, R. , Pawarode, A. , Perales, M. A. & 11 others 2017 (Accepted/In press) In : British Journal of Haematology.Research output: Contribution to journal › Article
Extranodal NK-T-Cell Lymphoma
Natural Killer T-Cells
T-Cell Lymphoma
Cell Transplantation
Nose
Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation
Zeng, Y. & Katsanis, E. Dec 1 2017 In : Bone Marrow Transplantation. 52, 12, p. 1671-1673 3 p.Research output: Contribution to journal › Letter
Cell Transplantation
blinatumomab
1
Citations
Alternative Donor Hematopoietic Cell Transplantation Conditioned with Myeloablative Busulfan, Fludarabine, and Melphalan is Well Tolerated and Effective Against High-risk Myeloid Malignancies
Katsanis, E., Sapp, L. N., Pelayo-Katsanis, L., Whitney, K., Zeng, Y. & Kopp, L. M. Nov 1 2016 In : Journal of Pediatric Hematology/Oncology. 38, 8, p. e315-e318Research output: Contribution to journal › Article
Busulfan
Melphalan
Cell Transplantation
Tissue Donors
Transplants